Proteome analysis of the transformation potential of the Epstein-Barr virus-encoded latent membrane protein 1 in nasopharyngeal epithelial cells NP69

Molecular and Cellular Biochemistry

Volumn 314, Issue 1-2, 2008, Pages 73-83

  Zhang, Qiong ^a   Zhang, Zhiwei ^a   Wang, Chengkun ^a   Xiao, Zhiqiang ^b   Yu, Yanhui ^a   Yang, Fang ^a   Chen, Zhuchu ^b   He, Zhimin ^a  

^a Central South University   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

EBV LMP1; Nasopharyngeal epithelial; Proteome analysis; Transformation

Indexed keywords

LATENT MEMBRANE PROTEIN 1; MUTANT PROTEIN; PROTEOME; RETROVIRUS VECTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NASOPHARYNX; PHENOTYPIC VARIATION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING; WILD TYPE;

CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPITHELIAL CELLS; HUMANS; NASOPHARYNX; PROTEIN STRUCTURE, TERTIARY; PROTEOME; TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR STEM CELL ASSAY; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 45449088884     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9767-8     Document Type: Article

References (39)

1. Bonnet M, Guinebretiere JM, Kremmer E et al (1999) Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 91:1376-1381
2. Pagano JS (1999) Epstein-Barr virus: The first human tumor virus and its role in cancer. Proc Assoc Am Physicians 111:573-580
3. Mosialos G (2001) Cytokine signaling and Epstein-Barr virus-mediated cell transformation. Cytokine Growth Factor Rev 12:259-270
4. Uchida J, Yasui T, Takaoka-Shichijo Y et al (1999) Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 286:300-303
5. Larcher C, Bernhard D, Schaadt E et al (2003) Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): Implications for a new role of naturally occurring LMP1 variants. Haematologica 88:1324-1335
6. Mainou BA, Everly DN Jr, Raab-Traub N (2005) Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 24:6917-6924
7. Xin B, He Z, Yang X (2001) TRADD domain of Epstein-Barr virus transforming protein LMP1 is essential for inducing immortalization and suppressing senescence of primary rodent fibroblasts. J Virol 75:3010-3015
8. Kim KR, Yoshizaki T, Miyamori H et al (2000) Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene 19:1764-1771
9. Dawson CW, Tramountanis G, Eliopoulos AG et al (2003) Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J Biol Chem 278:3694-3704
10. Hatzivassiliou E, Mosialos G (2002) Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1. Front Biosci 7:d319-d329
11. He Z, Xin B, Yang X et al (2000) Nuclear factor-kappaB activation is involved in LMP1-mediated transformation and tumorigenesis of rat-1 fibroblasts. Cancer Res 60:1845-1848
12. Izumi KM, Kaye KM, Kieff ED (1997) The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc Natl Acad Sci USA 94:1447-1452
13. Kilger E, Kieser A, Baumann M et al (1998) Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. Embo J 17:1700-1709
14. Yang X, Sham JS, Ng MH et al (2000) LMP1 of Epstein-Barr virus induces proliferation of primary mouse embryonic fibroblasts and cooperatively transforms the cells with a p16-insensitive CDK4 oncogene. J Virol 74:883-891
15. Tsao SW, Wang X, Liu Y et al (2002) Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim Biophys Acta 1590:150-158
16. Gorg A, Obermaier C, Boguth G et al (2000) The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21:1037-1053
17. Candiano G, Bruschi M, Musante L et al (2004) Blue silver: A very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25:1327-1333
18. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 25:402-408
19. Cohen-Kerem R, Lahat N, Elmalah I et al (2002) Detection of cytokeratins in normal and malignant laryngeal epithelia by means of reverse transcriptase-polymerase chain reaction. Ann Otol Rhinol Laryngol 111:149-154
20. Pollack V, Scheiber K, Pfaller W et al (1997) Loss of cytokeratin expression and formation of actin stress fibers in dedifferentiated MDCK-C7 cell lines. Biochem Biophys Res Commun 241:541-547
21. Stammberger P, Baczako K (1999) Cytokeratin 19 expression in human gastrointestinal mucosa during human prenatal development and in gastrointestinal tumors: Relation to cell proliferation. Cell Tissue Res 298:377-381
22. Lo AK, Liu Y, Wang XH et al (2003) Alterations of biologic properties and gene expression in nasopharyngeal epithelial cells by the Epstein-Barr virus-encoded latent membrane protein 1. Lab Invest 83:697-709
23. Lo AK, Huang DP, Lo KW et al (2004) Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells. Int J Cancer 109:919-925
24. Hsu WM, Hsieh FJ, Jeng YM et al (2005) Calreticulin expression in neuroblastoma - a novel independent prognostic factor. Ann Oncol 16:314-321
25. Yoon GS, Lee H, Jung Y et al (2000) Nuclear matrix of calreticulin in hepatocellular carcinoma. Cancer Res 60:1117-1120
26. Le Naour F, Brichory F, Misek DE et al (2002) A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis. Mol Cell Proteomics 1:197-203
27. Hong SH, Misek DE, Wang H et al (2004) An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer. Cancer Res 64:5504-5510
28. Kageyama S, Isono T, Iwaki H et al (2004) Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clin Chem 50:857-866
29. Mai J, Waisman DM, Sloane BF (2000) Cell surface complex of cathepsin B/ annexin II tetramer in malignant progression. Biochim Biophys Acta 1477:215-230
30. Chiang Y, Rizzino A, Sibenaller ZA et al (1999) Specific down-regulation of annexin II expression in human cells interferes with cell proliferation. Mol Cell Biochem 199:139-147
31. Hajjar KA, Acharya SS (2000) Annexin II and regulation of cell surface fibrinolysis. Ann NY Acad Sci 902:265-271
32. Chetcuti A, Margan SH, Russell P et al (2001) Loss of annexin II heavy and light chains in prostate cancer and its precursors. Cancer Res 61:6331-6334
33. Liu JW, Shen JJ, Tanzillo-Swarts A et al (2003) Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene 22:1475-1485
34. Liu SH, Lin CY, Peng SY et al (2002) Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation. Am J Pathol 160:1831-1837
35. Schwartz-Albiez R, Koretz K, Moller P et al (1993) Differential expression of annexins I and II in normal and malignant human mammary epithelial cells. Differentiation 52:229-237
36. Smith PD, Moss SE (1994) Structural evolution of the annexin supergene family. Trends Genet 10:241-246
37. Balch C, Dedman JR (1997) Annexins II and V inhibit cell migration. Exp Cell Res 237:259-263
38. Xin W, Rhodes DR, Ingold C et al (2003) Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol 162:255-261
39. Smitherman AB, Mohler JL, Maygarden SJ et al (2004) Expression of annexin I, II and VII proteins in androgen stimulated and recurrent prostate cancer. J Urol 171:916-920